Literature DB >> 26308180

Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues.

Andrew T Bockus1, Joshua A Schwochert1, Cameron R Pye1, Chad E Townsend1, Vong Sok1, Maria A Bednarek2, R Scott Lokey1.   

Abstract

It is well established that intramolecular hydrogen bonding and N-methylation play important roles in the passive permeability of cyclic peptides, but other structural features have been explored less intensively. Recent studies on the oral bioavailability of the cyclic heptapeptide sanguinamide A have raised the question of whether steric occlusion of polar groups via β-branching is an effective, yet untapped, tool in cyclic peptide permeability optimization. We report the structures of 17 sanguinamide A analogues designed to test the relative contributions of β-branching, N-methylation, and side chain size to passive membrane permeability and aqueous solubility. We demonstrate that β-branching has little effect on permeability compared to the effects of aliphatic carbon count and N-methylation of exposed NH groups. We highlight a new N-methylated analogue of sanguinamide A with a Leu substitution at position 2 that exhibits solvent-dependent flexibility and improved permeability over that of the natural product.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26308180     DOI: 10.1021/acs.jmedchem.5b00919

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

1.  Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as Therapeutics.

Authors:  Spiros Liras; Kim F Mcclure
Journal:  ACS Med Chem Lett       Date:  2019-06-14       Impact factor: 4.345

2.  Oxadiazole grafts in peptide macrocycles.

Authors:  John R Frost; Conor C G Scully; Andrei K Yudin
Journal:  Nat Chem       Date:  2016-10-24       Impact factor: 24.427

3.  Structural and conformational determinants of macrocycle cell permeability.

Authors:  Björn Over; Pär Matsson; Christian Tyrchan; Per Artursson; Bradley C Doak; Michael A Foley; Constanze Hilgendorf; Stephen E Johnston; Maurice D Lee; Richard J Lewis; Patrick McCarren; Giovanni Muncipinto; Ulf Norinder; Matthew W D Perry; Jeremy R Duvall; Jan Kihlberg
Journal:  Nat Chem Biol       Date:  2016-10-17       Impact factor: 15.040

4.  Conformational Restriction of Peptides Using Dithiol Bis-Alkylation.

Authors:  L Peraro; T R Siegert; J A Kritzer
Journal:  Methods Enzymol       Date:  2016-06-24       Impact factor: 1.600

5.  Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.

Authors:  Heba Salim; Jian Song; Ashweta Sahni; Dehua Pei
Journal:  J Org Chem       Date:  2019-10-28       Impact factor: 4.354

Review 6.  Understanding and designing head-to-tail cyclic peptides.

Authors:  Diana P Slough; Sean M McHugh; Yu-Shan Lin
Journal:  Biopolymers       Date:  2018-03-12       Impact factor: 2.505

Review 7.  Macrocycles as protein-protein interaction inhibitors.

Authors:  Patrick G Dougherty; Ziqing Qian; Dehua Pei
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857

8.  Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1.

Authors:  Walaa Bedewy; Hui Liao; Nageh A Abou-Taleb; Sherif F Hammad; Tamer Nasr; Dehua Pei
Journal:  Org Biomol Chem       Date:  2017-05-31       Impact factor: 3.876

Review 9.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.

Authors:  Xu Ran; Jason E Gestwicki
Journal:  Curr Opin Chem Biol       Date:  2018-06-13       Impact factor: 8.822

10.  Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.

Authors:  Joshua Schwochert; Yongtong Lao; Cameron R Pye; Matthew R Naylor; Prashant V Desai; Isabel C Gonzalez Valcarcel; Jaclyn A Barrett; Geri Sawada; Maria-Jesus Blanco; R Scott Lokey
Journal:  ACS Med Chem Lett       Date:  2016-06-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.